Overview

• UK ministers are in active discussions with pharmaceutical firms to address the potential impact of US-imposed tariffs on medicine exports.
• The US president has vowed to impose tariffs on pharmaceutical imports, with the industry bracing for levies potentially as high as 25%.
• Industry experts warn that tariffs could disrupt global supply chains, threatening medicine availability and pressuring UK pharmaceutical prices.
• Political and industry figures, including the Liberal Democrats, are calling for an emergency taskforce to secure medicine supplies for the NHS.
• Pharmaceutical companies are preparing for potential disruptions by implementing strategies like dual sourcing and scenario planning.